> Products > CAS NO 103909-75-7

China CAS NO 103909-75-7 Factory

Bear "Customer 1st, Good quality first" in mind, we work closely with our prospects and supply them with efficient and professional services for CAS NO 103909-75-7,103909-75-7,Maxacalcitol API,Maxacalcitol, should you might have any query or wish to place an initial get be sure to usually do not wait to get hold of us.
CAS NO 103909-75-7, In order to make more people know our items and to enlarge our market, we've got devoted a lot of attention to technical innovations and improvement, as well as replacement of equipment. Last but not the least, we also pay more attention to training our managerial personnel, technicians and workers in planned way.

Hot Products

1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL]-
Product Name:1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL]-
Molecular Formula:C21H21N3O5
Molecular Weight:395.41
CAS Registry Number:446292-07-5
Methyltriphenylphosphonium bromide
Product Name:Methyltriphenylphosphonium bromide
Molecular Formula:C19H18BrP
Molecular Weight:357.22
CAS Registry Number:1779-49-3
trans-4-Phenyl-L-proline
Product Name:trans-4-Phenyl-L-proline
Molecular Formula:C11H13NO2
Molecular Weight:191.23
CAS Registry Number:96314-26-0
NEODYMIUM 2-ETHYLHEXANOATE
Product Name:NEODYMIUM 2-ETHYLHEXANOATE
Molecular Formula:C8H16NdO2
Molecular Weight:288.46
CAS Registry Number:73227-23-3
9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
Product Name:9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
Molecular Formula:C30H35ClN4O2
Molecular Weight:519.09
CAS Registry Number:1256589-74-8
Ds-(+)-threo-Isocitric acid monopotassium salt
Product Name:Ds-(+)-threo-Isocitric acid monopotassium salt
Molecular Formula:C6H7KO7
Molecular Weight:230.21
CAS Registry Number:20226-99-7

Related Blog
Reviews

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)
Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.
Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates
In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.
How to find the best China API manufacturer?
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

China CAS NO 103909-75-7 Factory

Related Products

Hot Products

1H-ISOINDOLE-1,3(2H)-DIONE, 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL]-

Methyltriphenylphosphonium bromide

trans-4-Phenyl-L-proline

NEODYMIUM 2-ETHYLHEXANOATE

9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride

Ds-(+)-threo-Isocitric acid monopotassium salt

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

How to find the best China API manufacturer?

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Carey 2023-06-14 06:54:45

Adelaide 2022-04-13 12:58:22

Quyen Staten 2022-09-02 23:56:10

Martina 2022-10-20 11:14:49

Sara 2023-01-23 21:34:08

Prudence 2022-05-28 21:15:21

Send Inquiry